Investing
Neuralink gets FDA approval for ‘in-human’ trials of its brain-computer interface
Elon Musk’s brain-computer interface (BCI) startup, Neuralink, reportedly received approval from the United States Food and Drug Administration (FDA) to conduct some form of “in-human” trials for its surgically implanted brain device.
It’s unclear at this time what kind of trials the Neuralink tweet is referring to — the only other information mentioned was that the company isn’t accepting applicants yet.
Continue Reading on Coin Telegraph
Read the full article here
Barbara Corcoran: 5% Rate Would Make the Market Go Ballistic
Why Donald Trump’s Business-First Policies Trump Harris’ Consumer-Centric Approach
Not Backing up Your Phone? This is Why You Need to Start.
The App That Makes You Think Like a CEO
Swiss voters reject more powers for landlords on subletting By Reuters
The DOJ Reportedly Wants Google to Sell Its Chrome Browser
How to Create a Unique Value Proposition (With Tips & Examples)
This Founder Turned a Hangover Cure into Millions
Are You Missing These Hidden Warning Signs When Hiring?
7 Common Things You Should Never Buy New
Debt ceiling debate and its effect on the U.S. dollar
Debt ceiling default: Still no deal between parties
Stovall: If the U.S. defaults on its debt, all S&P 500 sectors will likely fall
What China's weaker-than-expected economy could mean for U.S. markets
A ‘Big Short’ investor sees financial disaster brewing in housing markets — again
-
Side Hustles5 days agoThe DOJ Reportedly Wants Google to Sell Its Chrome Browser
-
Side Hustles5 days agoHow to Create a Unique Value Proposition (With Tips & Examples)
-
Investing6 days agoThis Founder Turned a Hangover Cure into Millions
-
Investing4 days agoAre You Missing These Hidden Warning Signs When Hiring?
-
Make Money4 days ago7 Common Things You Should Never Buy New
-
Investing4 days agoGoogle faces call from DuckDuckGo for new EU probes into tech rule compliance By Reuters
-
Passive Income5 days agoHow AI Can (and Should) Drive Innovation Across Your Entire Company
-
Investing5 days agoBarbara Corcoran, Lori Greiner Differ on ‘Quiet Vacationing’